MAP Kinase Signaling
Phospho-(Thr) MAPK/CDK Substrate Mouse mAb |
イイネ!(0) |
|
|
| CSTコード | 包装 | 希望納入価格 (円) |
||
|---|---|---|---|---|
| #2321S | 100 μL | 57,000 | ログインすると国内在庫状況がご確認いただけます。
|
下記ステップについては、データシートの右側もあわせてご参照ください。
IHC-P: 抗体希釈液 / 抗原賦活化
| 用途(希釈倍率) | |
|---|---|
| ウェスタンブロッティング(1:5,000)、免疫組織染色(1:50)、ELISA-peptide(1:1,000) |
| 種交差性 | |
|---|---|
| すべての種 |
| 特異性・感度 | |
|---|---|
| プロリンが次にくるリン酸化スレオニンを検出します。スレオニン-プロリンの前後の配列に関わらず、リン酸化スレオニン-プロリンを有するタンパク質およびペプチドと反応します。プロリンが隣接していないリン酸化スレオニンは検出しません。リン酸化チロシンとは交差反応しませんが、リン酸化セリン-プロリンモチーフを含むリン酸化セリンペプチド(リン酸化Elk-1など)とは交差反応することがあります。 |
| 使用抗原 | |
|---|---|
| リン酸化スレオニン-プロリン モチーフを含むペプチド(合成ペプチド) |
| モチーフ | |
|---|---|
| T*P |
| 抗体の由来 | |
|---|---|
| マウス |
| 貯法 | |
|---|---|
| -20℃ |
| 社内データ |
|---|
Western Blotting

Western blot analysis of extracts from Jurkat cells, untreated or nocodazole-treated (1 µg/ml for 12 hours prior to lysis) and subjected to 2-D gel electrophoresis, using Phospho-(Thr) MAPK/CDK Substrate Mouse mAb.
Western Blotting

Western blot analysis of extracts from COS cells, untreated or treated with serum and okadaic acid, using Phospho-(Thr) MAPK/CDK Substrate Mouse mAb (left). The right panel shows total protein staining.
IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded human transitional epithelial carcinoma of the bladder, using Phospho-(Thr) MAPK/CDK Substrate Mouse mAb.
IHC-P (paraffin)

Immunohistochemical analyisis of paraffin-embedded human breast carcinoma, showing staining of proteins containing phospho-threonine-proline motifs, using Phospho-(Thr) MAPK/CDK Substrate Mouse mAb.
IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded human colon carcinoma, using Phospho-(Thr) MAPK/CDK Substrate Mouse mAb.
IHC-P (paraffin)

Immunohistochemical analysis of paraffin-embedded human breast carcinoma control (left) or lambda phosphatase-treated (right), using Phospho-(Thr) MAPK/CDK Substrate Mouse mAb.
| バックグラウンド |
|---|
The MAPK and CDK families of serine/threonine protein kinases play important roles in cell signaling and cell cycle control. These kinases phosphorylate threonine or serine followed by a proline residue (1-6). To study and discover new MAPK and CDK substrates, Cell Signaling Technology has developed antibodies that bind to phospho-threonine followed by proline.
As determined by ELISA using a wide variety of phospho-Thr-Pro peptides, Phospho-(Thr) MAPK/CDK Substrate Monoclonal Antibody recognizes the phospho-Thr-Pro motif in a highly context-independent fashion. It also interacts with a broad range of phospho-Thr-Pro-containing proteins as determined by Western blot analysis of nocodazole-treated Jurkat cell extracts resolved on a 2-D gel.
- Pearson, R.B. and Kemp, B.E. (1991) Methods Enzymol 200, 62-81.
- Seger, R. and Krebs, E.G. (1995) FASEB J 9, 726-35.
- Nurse, P. (2000) Cell 100, 71-8.
- Cross, T.G. et al. (2000) Exp Cell Res 256, 34-41.
- Yang, C.C. et al. (1998) J Protein Chem 17, 329-35.
- Reynolds, C.H. et al. (2000) J Neurochem 74, 1587-95.
| 使用文献 |
|---|
- Wada, T. et al. (2001) J Biol Chem 276, 30892-7. Applications: Western Blot Western Blotting
- Conover, C.A. et al. (2000) Endocrinology 141, 3098-103. Applications: Western Blotting
- Thiel, D.A. et al. (2002) Curr Biol 12, 1227-32. Applications: Western Blotting
- Monje, P. et al. (2003) Mol Cell Biol 23, 7030-43. Applications: Western Blotting
- Sugiura, R. et al. (2003) Nature 424, 961-5. Applications: Western Blotting
- Matter, N. et al. (2002) Nature 420, 691-5. Applications: Western Blotting
- Grønborg, M. et al. (2002) Mol Cell Proteomics 1, 517-27. Applications: IP
- Díaz-Rodríguez, E. et al. (2002) Mol Biol Cell 13, 2031-44. Applications: Western Blotting
- Rashid, T. et al. (2001) J Biol Chem 276, 49043-52. Applications: Western Blot
- Hall, C. et al. (2001) Mol Cell Biol 21, 1854-65. Applications: Western Blot
- Marinissen, M.J. et al. (2001) Genes Dev 15, 535-53. Applications: Western Blot
本製品は試験研究用です。

